Rebecca Gardner

16PUBLICATIONS
127CO-AUTHORS
HaematologyMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 17, 2026
HLH-like syndromes associate with increased risk of death and CD19-negative relapse post-CAR T in pediatric B-ALL.

|Jun 18, 2026
The first-in-human ENCIT01 trial comparing second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastoma.

|Apr 06, 2026
Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response.

Stosh Ozog, Elizabeth M Krantz, Karyn Tindbaek

|Feb 17, 2026
CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multisite, retrospective cohort review.

Alexander W Rankin, Regina M Myers, Adam J Lamble

|Jan 30, 2026
Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing Collaboration.

Yimei Li, Yang Qiao, Fei Gao

|Aug 19, 2025
International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML.

Swati Naik, Richard Aplenc, Susanne H C Baumeister

Pageof 3

Frequent Collaborators

7 joint publications

Wenjun Huang

7 joint publications

Julie R Park

5 joint publications

Ashley L Wilson

5 joint publications

Nirali N Shah